QURE Stock Analysis: Buy, Sell, or Hold?
QURE - uniQure N.V.
$41.81
-3.36 (-7.44%)
▼
5d:
-14.85%
30d:
+56.24%
90d:
+147.54%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Accumulation
None View Scanner →
Strength: 8.0/10
Get Alerted When QURE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: QURE is down 14.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: QURE is down 14.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: QURE is currently trading at $41.81, which is considered slightly high relative to its 30-day fair value range of $25.23 to $44.86.
Technical Outlook: Technically, QURE is in a strong uptrend. The price is currently testing key support at $41.15. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $64.53 (+54.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QURE is in a strong uptrend. The price is currently testing key support at $41.15. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $64.53 (+54.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$25.23 -
$44.86
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.6%
Protect Your Profits
Holding QURE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.4%)
- BULLISH: Trading 54.3% below Wall St target ($64.53)
- WARNING: Recommendation downgraded due to -14.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$25.23 -
$44.86
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$41.15
Resistance Level
$50.47
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.58
Wall Street Target
$64.53
(+54.3%)
Revenue Growth (YoY)
127.3%
Earnings Growth (YoY)
-18.2%
Share & Embed Analysis
Last updated: July 02, 2026 10:48 PM ET
Data refreshes hourly during market hours. Next update: 11:48 PM
Data refreshes hourly during market hours. Next update: 11:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QURE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeannette Potts
SELL
3412 shares
2026-03-04
Matthew C Kapusta
SELL
14581 shares
2026-03-04
Walid Abi-Saab
SELL
808 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$291 | 63 BUY |
Advanced QURE Option Strategies
Professional options setups generated by AI based on today's QURE price and gamma walls.
